Penn Today Online

Related Links

Find a Transplant Specialist:

-

Heart Transplant

-

Kidney/Pancreas Transplant

-

Liver Transplant

-

Lung Transplant

Make a Referral Online or call 1-800-789-PENN
Penn Transplant Center

Patient Education Articles:

-

Heart Transplant

-

Kidney Transplant

-

Liver Transplant

-

Lung Transplant

-

Pancreas Transplant

 


 Penn Today Online

Current Issue
Robotic Partial Nephrectomy for Renal Cell Carcinoma
Minimally Invasive Thyroidectomy for Follicular Neoplasm
Prosthetic Replacement for TMJ Degeneration
Nonsurgical Treatment of Desmoid Tumors
Orthopaedic Trauma Service at Penn
Physician Announcements
Archive of Articles
 
Subscribe to the Newsletter
Newsletter RSS Feed RSS feed
   

Home
Penn Today Online
Referral Directory
Physician Tools
Urgent Patient Transfer
Research
Upcoming CMEs

Clinical Briefing: Transplantation for Diabetic Patients with Kidney Disease

March/April 2008

Home to one of the oldest and most-established kidney transplant programs in the world, the Penn Transplant Institute is among the few transplant centers currently providing comprehensive care for diabetic patients with end-stage renal disease (ESRD). Diabetes is associated with a mortality rate that exceeds 50% within three years of dialysis initiation.

Given these risks, preemptive kidney transplantation from a living donor is the preferred treatment at Penn for eligible patients with diabetic nephropathy. Preemptive kidney transplantation has been found to result in dramatic survival and quality of life benefits to patients with advanced kidney disease.

For patients with type 1 diabetes, the Penn Transplant Institute offers the option of pancreas transplantation. The pancreas is most often transplanted simultaneously with a kidney (simultaneous pancreas/kidney transplant, or SPK). Patients who receive a living donor kidney may subsequently receive a pancreas at a later time (pancreas after kidney, or PAK). Islet after kidney transplantation is available for selected patients as part of an investigational study.

Case Study
Mr. L, a 47-year-old man with type 1 diabetes and stage 4 chronic kidney disease, was referred to the Penn Transplant Institute for evaluation. Comorbidities related to diabetes included retinopathy, gastroparesis and labile hyperglycemia.

On examination, Mr. L's BMI was 28, BP 150/77 mmHg, pulse was 86 bpm. Medications included insulin glargine 24 U/d, cinacalcet HCl 180 mg/d, furosemide 40 mg/d, lisinopril 20 mg/d and epoetin alfa 5,000 U/wk. Laboratory evaluation revealed a random serum glucose level at 174 mg/dl; C-peptide 0.45 ng/ml; BUN 62 mg/dl; serum creatinine (Cr) 4.8 mg/dl; and albumin 3.8 g/dl. A persantine-MIBI cardiac stress test was negative. Mr. L was placed on the regional waiting list for a simultaneous pancreas-kidney transplant.

At this time, Mr. L's wife – 42 years old, in excellent health with normal kidney function – was determined to be a compatible living kidney donor. Mr. L's residual kidney function declined progressively. His estimated GFR 11 months later was 12 ml/min; he had increasing fatigue and anorexia.

Mr. L and his wife decided to proceed with a pre-emptive living donor kidney transplantation; he would remain on the waiting list for a subsequent pancreas. Kidney transplantation was accomplished following laparoscopic nephrectomy from Mrs. L. Both patients had uneventful recoveries.

“Successful transplantation in diabetic patients with advanced kidney disease can result in substantial improvement in life expectancy and profound improvements in quality of life.”

Roy D. Bloom, MD
Medical Director,
Penn Kidney/Pancreas Transplant Program

Six months post-transplantation, Mr. L had a Cr of 1.4 mg/dl and felt “great” other than symptoms related to intermittent hypoglycemia. The next year, he underwent successful pancreas transplantation and experienced immediate euglycemia. His HgbA1c was 5.7% within four months of transplant. Today, more than three years after living donor kidney transplantation and 20 months after pancreas transplant, his prognosis is considered excellent.

Our Team of Faculty
An international leader in kidney transplantation, the Penn Transplant Institute is comprised of a multidisciplinary team of specialists with expertise in managing transplant-related issues pertaining to kidney diseases, infectious diseases, diabetes, cardiology, radiology and nephropathology.

These clinicians are strongly supported by an experienced and dedicated infrastructure of personnel whose common goal is to work with patients, their families and primary nephrologists to provide comprehensive care for renal transplant patients. This network of providers develops individualized treatment and follow-up care from initial evaluation through postoperative care and beyond.

Transplant Nephrology

Roy D. Bloom, MD
Medical Director, Kidney/Pancreas Transplant Program
Associate Professor of Medicine

Robert A. Grossman, MD
Professor of Medicine

Simin Goral, MD
Associate Professor of Medicine

Alden M. Doyle, MD, MPH, MS
Assistant Professor of Medicine

Karen Warburton, MD
Assistant Professor of Clinical Medicine

Transplant Surgery

Ali Naji, MD, PhD
Surgical Director, Kidney Transplant Program;
J. William White Professor of Surgical Research

Peter L. Abt, MD
Assistant Professor of Surgery

Clyde F. Barker, MD
John Rhea Barton Professor of Surgery;
Donald Guthrie Professor of Surgery

Transplant Pharmacist

Jennifer Trofe, PharmD
Adjunctive Assistant Professor of Medicine

Transplant Infectious Diseases

Emily Blumberg, MD
Associate Professor of Medicine

Nephrology

Hospital of the University of Pennsylvania
Jeffrey S. Berns, MD
Professor of Medicine and Pediatrics

Debbie Cohen, MD
Assistant Professor of Medicine

Joel Glickman, MD*
Clinical Associate Professor of Medicine

Robert Grossman, MD
Professor of Medicine

Sidney Kobrin, MD*
Associate Professor of Medicine

Raymond Townsend, MD
Professor of Medicine

Alan Wasserstein, MD
Associate Professor of Medicine

Penn Presbyterian Medical Center
Raphael Cohen, MD
Clinical Associate Professor of Medicine

Brenda Hoffman, MD
Associate Professor of Clinical Medicine

Michael Rudnick, MD
Associate Professor of Medicine

Renal Pathology

John Tomaszewski, MD
Professor of Pathology and Laboratory Medicine

*Also at Penn Medicine at Radnor

Selected Clinical Studies

  • Clinical, Immunologic, and Pharmacologic Consequences of Kidney Transplantation in People with HIV Infection
  • Coronary Screening for Kidney Transplantation (COST study)
  • Use of Novel Immunosuppressive Agents in Kidney Transplantation e.g. Belatacept, AEB, ISA 247, Alafacept
  • Outcomes in Kidney Transplant Patients with Hepatitis C Infection
  • Arterial Mechanics after Kidney Donation
  • Cardiovascular Disease and Coronary Calcification in Kidney Recipients

Access
Patient appointments are available at:

Penn Transplant Institute
Kidney and Pancreas Transplant Program
Hospital of the University of Pennsylvania
Rhoads Ground Level
3400 Spruce Street
Philadelphia, PA 19104

To refer a patient and/or consult with a doctor:

 


Referring Physicians: To speak with a Penn physician or refer a patient, contact PennHealth through the secure online referral form or by calling
1-800-789-PENN (7366).

   
   

 

About UPHS   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

The University of Pennsylvania Health System, Philadelphia, PA 800-789-PENN © 2008, The Trustees of the University of Pennsylvania